FDA authorizes prescription BinaxNOW COVID-19 test for home use

The Food and Drug Administration yesterday authorized a prescription BinaxNOW COVID-19 test for use by patients at home, in partnership with a telehealth service that will take users through the sample collection process and assist in reading and understanding the results.

The telehealth provider also will report all test results to the relevant public health authorities as required. FDA in August authorized a different version of the test for use at the point of care.